Showing results (51-60 of 143) with videos related to
Sort By:
Pageof 15
Chemistry Central Journal|June 16, 2011
A validated stability-indicating HPLC method for determination of varenicline in its bulk and tabletsAdnan A Kadi, Mostafa S Mohamed, Mohamed G Kassem, et al.RSC Advances|May 2, 2022
Identification and characterization of <i>in silico</i>, <i>in vivo</i>, <i>in vitro</i>, and reactive metabolites of infigratinib using LC-ITMS: bioactivation pathway elucidation and <i>in silico</i> toxicity studies of its metabolitesNasser S Al-Shakliah, Mohamed W Attwa, Adnan A Kadi, et al.Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|September 18, 2020
Development and validation of an HPLC-MS/MS method for the determination of filgotinib, a selective Janus kinase 1 inhibitor: Application to a metabolic stability studyHaitham AlRabiah, Adnan A Kadi, Mohamed W Attwa, et al.Analytical Methods : Advancing Methods and Applications|January 7, 2021
Identification and characterization of <i>in vitro</i>, <i>in vivo</i>, and reactive metabolites of tandutinib using liquid chromatography ion trap mass spectrometryNasser S Al-Shakliah, Mohamed W Attwa, Haitham AlRabiah, et al.RSC Advances|May 13, 2022
Investigation of the metabolic stability of olmutinib by validated LC-MS/MS: quantification in human plasmaMohamed W Attwa, Adnan A Kadi, Hany W Darwish, et al.Chemistry Central Journal|May 17, 2018
Characterization of in vivo metabolites in rat urine following an oral dose of masitinib by liquid chromatography tandem mass spectrometryAdnan A Kadi, Sawsan M Amer, Hany W Darwish, et al.Molecules (Basel, Switzerland)|October 28, 2023
An Ultrafast UPLC-MS/MS Method for Characterizing the In Vitro Metabolic Stability of AcalabrutinibMohamed W Attwa, Ahmed H Bakheit, Ali S Abdelhameed, et al.Pharmaceutics|October 28, 2023
Evaluation of Alectinib Metabolic Stability in HLMs Using Fast LC-MS/MS Method: In Silico ADME Profile, P450 Metabolic Lability, and Toxic Alerts ScreeningMohamed W Attwa, Haitham AlRabiah, Gamal A E Mostafa, et al.Bio-Medical Materials and Engineering|May 6, 2008
Effect of cyclic stretching and TGF-beta on the SMAD pathway in fibroblastsA Kadi, S Fawzi-Grancher, G Lakisic, et al.Drug Design, Development and Therapy|March 12, 2020
Metabolic Stability Assessment of New PARP Inhibitor Talazoparib Using Validated LC-MS/MS Methodology: In silico Metabolic Vulnerability and Toxicity StudiesMohamed W Attwa, Adnan A Kadi, Ali S Abdelhameed, et al.Pageof 15